FDA recently met with industry stakeholders to discuss technical assessments that should be considered for devices manufactured using 3-D printing, with an agency official saying that the materials used, the process involved and the type of device should all be taken into account. FDA, in the Federal Register notice announcing the meeting, said it hoped to develop a more complete understanding of the technical challenges and solutions in additive manufacturing, create awareness of these technical challenges, and collaboratively develop...